Fig. 5

Diagnostic performance of biomarker panels for PDA. (a) All-stage PDA vs. healthy controls in Cohort A. (b) Early-stage PDA vs. healthy controls in Cohort A. (c) All-stage PDA vs. healthy controls in Cohort B. (d) Early-stage PDA vs. healthy controls in Cohort B.